Two-tiered DNA-based diagnosis transthyretin amyloidosis reveals novel point mutations consecutive unrelated cases polyneuropathy due amyloidosis Direct sequencing promoter region exons splice junctions patient heterozygous mutation patients valine methionine Portuguese-Japanese type threonine alanine Appalachian type serine tyrosine Illinois type addition patients mutation phenylalanine leucine leucine present information probands novel mutations pathology individuals mutations mutations range mutations amyloidotic polyneuropathy patients different mutations distinct clinical phenotypes PASA assays PCR amplification specific alleles mutations PASA diagnostic laboratory PCR known mutations minority samples undescribed mutation specialty laboratory delineation mutation direct genomic sequencing combination methods widespread utility diagnosis genetic disease 